Skin or Soft Tissue

Notes

Please review criteria to determine if your patient requires prophylaxis

In appropriate candidates, it is reasonable that the regimen administered for treatment of the infection contain an agent active against staphylococci and beta hemolytic streptococci.

An anti-staphylococcal penicillin or cephalosporin is preferable; vancomyin or clindamycin may be administered to patients unable to tolerate a beta-lactam or who are known or suspected to have an infection cause by MRSA.